Silvia Dossena

Silvia Dossena, PhD, is an Associate Professor and Interim Director at the Institute of Pharmacology and Toxicology, Paracelsus Medical University. Her research focuses on oxidative stress mechanisms in cellular aging, genetic determinants of hearing loss, and the pathophysiology of pendrin (SLC26A4) protein variants in Pendred syndrome/DFNB4 disorders.

• Active in molecular pharmacology and toxicology
• Supervisor of pharmacy research projects

Her work spans molecular biology, genetics, and pharmacology, with a strong emphasis on antioxidant therapies and ion transport systems. Recent studies highlight her exploration of proteasome inhibitors for rescuing pendrin function and natural compounds like Acai berry extract in combating erythrocyte aging. She has received multiple prestigious awards from Paracelsus Medical University, including the Platinum Price for Research (2014).

• Key projects include "Identification of novel therapeutic targets in Pendred syndrome/DFNB4"
• Active in peer-review and editorial work for journals like Current Molecular Pharmacology